drugset / Trial / NCT01684475

A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE

NCT01684475 ↗

Phase 1/2 Unknown 21 enrolled Alexandra Marine and General Hospital
NaSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the ability of CJH1 to increase the sensitivity of dopamine receptors and thereby reduce symptoms of Parkinson's Disease.

Timeline

Start
2012-09
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject CJH1 Unknown — —

Indications